Vital Bio is developing the VitalOne, a point-of-care lab testing platform that utilizes microfluidics and computer vision to deliver lab-grade results from a small blood sample in minutes. This technology enables patients and healthcare providers to access real-time diagnostic information, facilitating timely interventions and improving health management.
Funding
$61.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional lab testing often requires sending samples to centralized laboratories, resulting in long turnaround times and delayed clinical decision-making. This can hinder timely interventions, especially in point-of-care settings where immediate results are crucial.
Solution
Vital Bio is developing the VitalOne, a point-of-care diagnostic platform that delivers lab-grade results from a small blood sample within minutes. The system integrates microfluidics, robotics, biochemistry, and computer vision to automate and miniaturize complex laboratory assays. By providing rapid access to comprehensive diagnostic information at the patient's side, VitalOne aims to enable real-time care, facilitate early engagement, and close care gaps. The platform is designed to be used directly by healthcare providers, allowing for immediate clinical decisions and improved patient management.
Target Audience
The primary target audience includes healthcare providers, hospitals, and clinics seeking to improve patient care through rapid, point-of-care diagnostics.
Features
- Point-of-care lab testing platform providing results in minutes
- Utilizes a small blood sample for comprehensive analysis
- Integrates microfluidics, robotics, biochemistry, and computer vision technologies
- Automates and miniaturizes complex laboratory assays
- Designed for use in various healthcare settings, including clinics and hospitals